Exploring the relationship of SSTR2 immunohistochemical and textural features to neuroendocrine tumor grade

被引：0
|
作者：
Sherbansky, Leah
Savickas, Patrick
Phanse, Sharwari
Casey, Jack
Feldstein, Julie
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4315
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ct-based nomogram development and validation to predict SSTR2, VEGFR2, and mgmt expression for pancreatic neuroendocrine neoplasms
    Zhou, Xiaoqi
    Song, Chenyu
    Li, Lujie
    Wang, Yangdi
    Feng, Shi-Ting
    Luo, Yanji
    Peng, Zhenpeng
    GUT, 2023, 72 (SUPPL_1) : A200 - A201
  • [32] CT-based nomogram development and validation to predict SSTR2, VEGFR2 and MGMT expression for pancreatic neuroendocrine neoplasms
    Zhou X.
    Song C.
    Li L.
    Wang Y.
    Li Z.
    Feng S.-T.
    Luo Y.
    Peng Z.
    Chinese Journal of Academic Radiology, 2023, 6 (3) : 100 - 115
  • [33] Determination of somatostatin receptors types 2A and 5 (SSTR-2A, SSTR-5) expression in neuroendocrine tumors (NETs) and neuroendocrine carcinoma (NECs) of various localizations and grade
    Emelianova, G.
    Artamonova, E.
    Ushakov, A.
    Delektorskaya, V
    Markovich, A.
    Evdokimova, E.
    Gorbunova, V
    Bagrova, S.
    Kovalenko, E.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 89 - 89
  • [34] Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy
    Si, Yingnan
    Kim, Seulhee
    Ou, Jianfa
    Lu, Yun
    Ernst, Patrick
    Chen, Kai
    Whitt, Jason
    Carter, Angela M.
    Markert, James M.
    Bibb, James A.
    Chen, Herbert
    Zhou, Lufang
    Jaskula-Sztul, Renata
    Liu, Xiaoguang Margaret
    CANCER GENE THERAPY, 2021, 28 (7-8) : 799 - 812
  • [35] Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy
    Yingnan Si
    Seulhee Kim
    Jianfa Ou
    Yun Lu
    Patrick Ernst
    Kai Chen
    Jason Whitt
    Angela M. Carter
    James M. Markert
    James A. Bibb
    Herbert Chen
    Lufang Zhou
    Renata Jaskula-Sztul
    Xiaoguang “Margaret” Liu
    Cancer Gene Therapy, 2021, 28 : 799 - 812
  • [36] Expression of somatostatin receptor subtype 2 (sstr2) in neuroendocrine tumors studied by ribonuclease protection assay related to 111In-octreotide binding
    Nilsson, O
    Hashemi, S
    Benjegard, SA
    Forssell-Aronsson, E
    Billig, H
    Wangberg, B
    Ahlman, H
    GASTROENTEROLOGY, 1999, 116 (04) : A630 - A630
  • [37] Coefficient of Variation Assessed by 68Ga-DOTATOC-PET/ CT in the Evaluation of the Heterogeneity of SSTR2 Expression in Patients with Neuroendocrine Tumors
    Fonti, R.
    Pellegrino, S.
    Panico, M.
    Bologna, R.
    Morra, R.
    Giuliano, M.
    Palmieri, G.
    De Placido, S.
    Del Vecchio, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S473 - S474
  • [38] Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects With Advanced Neuroendocrine Tumors
    El-Rayes, Bassel F.
    Hendifar, Andrew E.
    Pant, Shubham
    Wilky, Breelyn A.
    Reilley, Matthew J.
    Benson, Al B.
    Chow, Warren A.
    Konda, Bhavana
    Starr, Jason
    Ahn, Daniel H.
    Kunz, Pamela L.
    Strosberg, Jonathan R.
    Eads, Jennifer R.
    Perez, Kimberly J.
    Raj, Nitya P.
    Fisher, George A.
    Chollate, Sowmya
    Fleener, Catherine A.
    Ding, Ying
    Tang, Zequn
    PANCREAS, 2022, 51 (03) : E58 - E58
  • [39] Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
    Fonti, Rosa
    Panico, Mariarosaria
    Pellegrino, Sara
    Pulcrano, Alessandro
    Vastarella, Luisa Alessia
    Torbati, Armin Hakkak Moghadam
    Giuliano, Mario
    Palmieri, Giovannella
    De Placido, Sabino
    Del Vecchio, Silvana
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1509 - 1514
  • [40] A case of pedunculated grade 2 neuroendocrine tumor in the ileum
    Umemura, Yuria
    Ohnita, Ken
    Akazawa, Yuko
    GASTROINTESTINAL ENDOSCOPY, 2023, 98 (06) : 1032 - 1033
12345